Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

P. Musto, L. Maurillo, V. Simeon, A. Poloni, C. Finelli, E. Balleari, A. Ricco, F. Rivellini, A. Cortelezzi, G. Tarantini, O. Villani, G. Mansueto, M.R. Milella, D. Scapicchio, G. Marziano, M. Breccia, P. Niscola, A. Sanna, C. Clissa, M.T. VosoS. Fenu, A. Venditti, V. Santini, E. Angelucci, A. Levis

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)741-750
Number of pages10
JournalBritish Journal of Haematology
Volume177
Issue number5
DOIs
Publication statusPublished - 2017

Cite this

Musto, P., Maurillo, L., Simeon, V., Poloni, A., Finelli, C., Balleari, E., Ricco, A., Rivellini, F., Cortelezzi, A., Tarantini, G., Villani, O., Mansueto, G., Milella, M. R., Scapicchio, D., Marziano, G., Breccia, M., Niscola, P., Sanna, A., Clissa, C., ... Levis, A. (2017). Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study. British Journal of Haematology, 177(5), 741-750. https://doi.org/10.1111/bjh.14621